All patients, irrespective of whether or not they are on the Liverpool Care Pathway (LCP) or any other integrated care pathway, should receive high quality, compassionate care in the last days and hours of life, and their families should be supported. But this is not always the case and we must address that inconsistency. In […]

A template to determine intervention data outputs by channel and projection calculations.

Best practice timed pathways support the ongoing improvement effort to shorten diagnosis pathways, reduce variation, improve patient experience of care, and meet the Faster Diagnosis Standard (FDS). The guidance is intended for NHS organisations and their staff to adopt consistent, system-wide approaches to managing cancer diagnosis pathways and sets out how cancer diagnosis within 28 days can be achieved.

The aim of this guidance is to ensure equitable access to oral healthcare for patients diagnosed with cancer across England. It provides clinical standards and example pathways to maximize cancer treatment outcomes.

Leading change Nurses in the Faecal INcontinence and Constipation Healthcare (FINCH) team at Sandwell and West Birmingham Hospitals introduced an innovative integrated care pathway (ICP) for their patients. It has had a positive impact on both patient outcomes and experience. Where to look Nurses and colleagues in the multi-disciplinary FINCH team identified unwarranted variation in […]

BI4: Improving Haemoglobinopathy Pathways through ODNs for Blood and Infection Programme of Care Schemes, which forms part of the 2016/17 Prescribed Specialised Services Commissioning for Quality and Innovation (CQUIN) schemes.

Lincolnshire West CCG were aiming to improve the quality and delivery of health services for their patients by working with their partners to deliver high-quality and coordinated, integrated healthcare.

This guidance sets out the joint genomic testing pathway that NHS England and the National Institute for Health and Care Excellence (NICE) have agreed to follow to identify, prioritise and assess new genomic technologies, before they are considered for commissioning by the NHS in England.